Tempur-Pedic International Inc. — Form 10-Q Summary
Entity note: The supplied filing is for Tempur-Pedic International Inc., not SOMNIGROUP INTERNATIONAL INC. It covers the quarter ended September 30, 2011, and compares the three- and nine-month periods with 2010. Amounts are in millions of dollars unless noted; the filing presents most financial statements in thousands.
Business context and period
Tempur-Pedic manufactures, markets and sells premium mattresses, pillows and related products under the TEMPUR and Tempur-Pedic brands in approximately 80 countries. It reports North America and International segments and sells through Retail, Direct, Healthcare and third-party channels. The filing is unaudited.
Financial performance
| Metric | Q3 2011 | Q3 2010 | Nine months 2011 | Nine months 2010 |
|---|---|---|---|---|
| Net sales | $383.1 | $295.8 | $1,051.1 | $812.7 |
| Gross profit / margin | $200.6 / 52.4% | $150.8 / 51.0% | $551.9 / 52.5% | $403.6 / 49.7% |
| Operating income / margin | $96.6 / 25.2% | $68.2 / 23.0% | $254.7 / 24.2% | $174.3 / 21.5% |
| Net income / margin | $61.9 / 16.2% | $44.2 / 15.0% | $163.3 / 15.5% | $110.9 / 13.6% |
| Diluted EPS | $0.90 | $0.62 | $2.34 | $1.51 |
| Operating cash flow | Not separately stated | Not separately stated | $179.0 | $139.7 |
For the nine months, capital expenditures were $18.8 million, so operating cash flow less capital expenditures was approximately $160.1 million, compared with $127.4 million in 2010. Cash and equivalents were $103.0 million at September 30, 2011, up from $53.6 million at year-end 2010; working capital was $194.4 million. Long-term debt was $508.5 million, versus $407.0 million at year-end. The filing reports $260.5 million of remaining revolver availability, including the effect of letters of credit. The company was in compliance with debt covenants; funded debt to EBITDA was 1.36x against a 3.0x maximum.
At September 30, current assets were $380.5 million and current liabilities $186.0 million. Stockholders’ equity was $99.4 million, down from $126.0 million at year-end.
Changes and drivers
- Q3 sales increased 29.5% year over year; nine-month sales increased 29.3%. Growth reflected marketing investment, new products, broader distribution and retail-account gains. North America sales rose 30.1% in Q3 and 31.7% year to date; International sales rose 27.9% and 23.6%, respectively. International growth excluding currency effects was approximately 15.4% in Q3 and 13.6% year to date.
- Mattresses were the largest growth contributor; adjustable bases, foundations and other products also grew. Retail remained the largest channel.
- Gross margin improved, attributed particularly to productivity gains, favorable mix, higher volume and fixed-cost leverage. Higher commodity costs and launch-related discounts were offsets. Q3 International margin was pressured by a Denmark manufacturing IT upgrade, temporary productivity issues and additional freight from shipping product from North America.
- Selling and marketing expense rose 36.1% in Q3 and 40.0% year to date; advertising expense rose 55.7% and 55.6%, respectively. Selling and marketing costs were a higher share of sales. General and administrative expense grew more slowly than revenue.
Outlook, risks and unusual items
- Management expected the global economic environment to remain challenging for the rest of 2011. It planned continued brand advertising, product development, distribution expansion and cost-structure optimization. It expected full-year 2011 gross margin to increase, supported by mix, productivity and volume leverage, partly offset by strategic investment and commodity costs.
- Expected 2011 capital expenditures were approximately $28 million, versus $18.8 million spent in the first nine months.
- The June 2011 amended credit facility provides aggregate availability of $770 million, matures June 28, 2016, and includes an option to increase domestic availability by $250 million. A four-year interest-rate swap is intended to fix the LIBOR-based rate at 1.25% on $250 million of borrowings beginning December 30, 2011. Management estimated that a 100-basis-point rate increase, holding other factors constant, would reduce next-year pretax income by about $7.6 million.
- The company repurchased $240 million of shares in the first nine months of 2011. A further $80 million was authorized in October, bringing the amount then available under the July authorization to $200 million; repurchases may be funded with operating cash or borrowings.
- A Danish tax dispute concerning intercompany royalties involves assessments of approximately $103.1 million, including interest and penalties, for tax years 2001–2005. Proceedings are on hold while U.S. and Danish authorities pursue a bilateral pricing agreement. The company says it intends to contest the assessments; the timing and outcome are uncertain.
- An antitrust class action remained subject to an en banc review petition after an appellate ruling favorable to the company. A separate New York Attorney General appeal concerns the company’s unilateral retail pricing policy. Management considered losses remote in both matters, while noting litigation uncertainty.
- The company acquired its South Korean third-party distributor in July for $4.6 million, with additional contingent payments tied to financial and operational targets. Management reported effective disclosure controls; IT-related control procedures at the Denmark facility were modified alongside the system upgrade.
Important facts for investors to verify
- Confirm the issuer identity: this document is Tempur-Pedic International Inc.’s filing, despite the SOMNIGROUP INTERNATIONAL INC. request metadata.
- Track whether strong sales growth and margin improvement persist, particularly if advertising, commodity costs, product mix or economic conditions change.
- Monitor debt, revolver availability, covenant headroom, interest-rate exposure and the funding of further share repurchases.
- Follow the Danish tax assessment and the antitrust and New York pricing-policy proceedings, including any change in estimated exposure.
- Assess execution of the Denmark IT upgrade and whether temporary production and freight impacts resolve; compare actual full-year capital spending with management’s estimate.